Patents by Inventor Mason YAMASHITA

Mason YAMASHITA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER TREATMENT
    Publication number: 20200318112
    Abstract: In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of STAT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-cell lymphoma or hepatocellular carcinoma.
    Type: Application
    Filed: February 28, 2020
    Publication date: October 8, 2020
    Inventors: Stanley T. CROOKE, Mason YAMASHITA
  • Cancer treatment
    Patent number: 10619157
    Abstract: In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of STAT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-cell lymphoma or hepatocellular carcinoma.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: April 14, 2020
    Assignee: Ionis Pharmaceuticals, Inc.
    Inventors: Stanley T. Crooke, Mason Yamashita
  • CANCER TREATMENT
    Publication number: 20180346907
    Abstract: In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of STAT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-cell lymphoma or hepatocellular carcinoma.
    Type: Application
    Filed: November 27, 2017
    Publication date: December 6, 2018
    Applicant: Ionis Pharmaceuticals, Inc.
    Inventors: Stanley T. CROOKE, Mason YAMASHITA
  • Cancer treatment
    Patent number: 9873876
    Abstract: In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of ST AT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-cell lymphoma or hepatocellular carcinoma. The STAT (signal transducers and activators of transcription) family of proteins are DNA-binding proteins that play a dual role in signal transduction and activation of transcription.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: January 23, 2018
    Assignee: Ionis Pharmaceuticals, Inc.
    Inventors: Stanley T. Crooke, Mason Yamashita
  • CANCER TREATMENT
    Publication number: 20170145413
    Abstract: In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of ST AT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-celllymphoma or hepatocellular carcinoma. The STAT (signal transducers and activators of transcription) family of proteins are DNA-binding proteins that play a dual role in signal transduction and activation of transcription.
    Type: Application
    Filed: November 21, 2016
    Publication date: May 25, 2017
    Applicant: Ionis Pharmaceuticals, Inc.
    Inventors: Stanley T. CROOKE, Mason YAMASHITA
  • Cancer treatment
    Patent number: 9540641
    Abstract: In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of STAT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-cell lymphoma or hepatocellular carcinoma. The STAT (signal transducers and activators of transcription) family of proteins are DNA-binding proteins that play a dual role in signal transduction and activation of transcription.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: January 10, 2017
    Assignee: Ionis Pharmaceuticals, Inc.
    Inventors: Stanley T. Crooke, Mason Yamashita
  • CANCER TREATMENT
    Publication number: 20160002625
    Abstract: In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of ST AT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-cell lymphoma or hepatocellular carcinoma. The STAT (signal transducers and activators of transcription) family of proteins are DNA-binding proteins that play a dual role in signal transduction and activation of transcription.
    Type: Application
    Filed: October 30, 2013
    Publication date: January 7, 2016
    Applicant: ISIS PHARMACEUTICALS INC.
    Inventors: Stanley T. CROOKE, Mason YAMASHITA